E. Solau

Characterization of skin Th17 transcriptional profiles in psoriatic patients under adalimumab biotherapy

L. Favot, J. Lecron, F. Morel, 2017, European Journal of Dermatology.

Factors influencing bone loss in rheumatoid arthritis: a longitudinal study.

X. Marchandise, B. Cortet, R. Flipo, 2000, Clinical and experimental rheumatology.

Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab

J. Sibilia, J. Berthelot, X. Puéchal, 2005, Annals of the rheumatic diseases.

Long-term results of infliximab therapy in rheumatoid arthritis: experience acquired by the North-Pas-de-Calais hospital network.

R. Flipo, B. Delcambre, E. Solau, 2007, Joint, bone, spine : revue du rhumatisme.

Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis.

G. Lizard, J. Sibilia, J. Morel, 2010, Joint, bone, spine : revue du rhumatisme.